SHS Webinar "Structuring Capital Raises: A Playbook from docjo.health & OOMNIUM"

With OOMNIUM, you close your fundraising round faster and more successfully. We allow companies to raise funds for growth in a lean and cost-effective way. Simultaneously, our platform enables investors to invest in exciting and promising start-ups and SMEs - with just a few clicks, fully digital and even with a small budget.

As part of our joint webinar with OOMNIUM on phase-based fundraising strategies, Iva Bozovic, CMO of OOMNIUM, spoke with Oliver Felix, CEO and Co-Founder of docjo.health. In this interview, Oliver shares first-hand insights from docjo’s recent financing round, reflecting on what worked, what he would do differently, and why structure, focus, and momentum were decisive throughout the process.

(The interview was conducted in German and translated for SHS)

You structured your campaign strategically and divided it into different phases. Did that prove successful for you?

Yes, absolutely. The phase structure was one of the core elements and also an important deciding factor for OOMNIUM. Each phase had its own character and target audience. The goal was to appeal to the broad OOMNIUM community in later phases, with the advantage that clear proof was already available from market experts and our founder and network environment. This sequence significantly strengthened the credibility and momentum of the round.

A financing round requires the attention of management. There were four of you involved—what were the advantages of this consistent focus on your round by all participants, and would you do it again?

Since we prepared the round in just under a month, it was crucial to have the entire core team on board, including all founders and board members. This was the only way to ensure that all expertise was available at all times and that it was possible to establish a viable structure in such a short period of time.

This will also help us in subsequent rounds, as the processes are now established. What I would do differently in the future is to have even clearer roles and teams. For example, a small team for finance, one for business and presentation, and one for legal issues to shorten iterations.

How did you perceive the support provided by OOMNIUM during the process? What was useful and what was not?

Very positive. Several people were involved, so the right expertise was available at all times. I particularly appreciated the fact that solutions were presented very quickly, even when challenges or errors arose. Every start-up has its own unique characteristics, and standard processes don't always work. The key is how you deal with this, and OOMNIUM was very professional in this regard.

The overall process was clearly structured, and partners such as LEXR and Aktionariat were also very well integrated.

Your round had very short investment windows of 7 days each. What is the advantage of this time frame, and when would you advise other founders to do the same?

We know that other companies sometimes had even shorter time frames. Our experience was clear: deliberately creating urgency, combined with graduated conditions according to phase based on the principle of “the earlier, the better,” creates a very positive dynamic.

Even if you initially think that seven days is too short, this has not been confirmed in practice. On the contrary: decision-making was clearly accelerated.

What general advice would you give to other founders who want to take out growth financing?

In the context of OOMNIUM, I believe it is essential to have lead investors on board from the outset. This is crucial for momentum in the first and second weeks.

Regardless of the platform, the key is to pool resources. It is better to have an intensive, focused fundraising block with full attention and then return to business operations than to have a process that is too long and fragmented. Urgency and attention are crucial.

What surprised you most personally about the whole process and handling via a digital platform?

How much your personal network can be expanded when you choose a structured process and a clear approach. And how decisive the momentum and urgency generated really are. I hadn't expected it to be so significant.

Is there an update on docjo.health that you would like to share with the SHS community?

As we all know, after the round is before the round. We are currently in advanced negotiations with pharmaceutical companies and health insurance providers.

To this end, we have deliberately left part of the round open in order to bring on board active investors who complement our expertise. These investors will benefit from attractive terms, but are also expected to provide operational added value in addition to their financial contribution.

The ticket size is > CHF 50k. Investors with strengths in market access, technological know-how, and a robust network are of particular interest, also with a view to further financing rounds.

Any references or contacts to suitable individuals are very welcome. Of course, interested parties can also contact me directly at any time.

12:00 Webinar starts
12:45 Q&A
13:00 End of the session

You are kindly requested to register only if you are planning on participating.
If you register and unfortunately can no longer attend, we kindly ask you to drop us an email to info@swisshealthcarestartups.com.

⚠️ Registration deadline: February 23, 2026 ⚠️

If you do not see the ticket form, please reload the page or click here.